US Senator

Ron Wyden 2025-2026 Regular Session - Authored & Sponsored Legislation

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1002

Introduced
3/12/25  
Deliver for Democracy Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB103

Introduced
1/15/25  
Extend the TikTok Deadline Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1032

Introduced
3/13/25  
Major Richard Star Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1068

Introduced
3/13/25  
Putting Veterans First Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1076

Introduced
3/14/25  
Preventing Illegal Weapons Trafficking Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1092

Introduced
3/24/25  
Refer
3/24/25  
WIPPES Act Wastewater Infrastructure Pollution Prevention and Environmental Safety Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1094

Introduced
3/24/25  
Mass Timber Federal Buildings Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1115

Introduced
3/25/25  
Paycheck Fairness Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1154

Introduced
3/26/25  
Congressional Whistleblower Protection Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1156

Introduced
3/26/25  
Food Secure Strikers Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1166

Introduced
3/27/25  
Excess Urban Heat Mitigation Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1172

Introduced
3/27/25  
Honor Farmer Contracts Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1186

Introduced
3/27/25  
Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1193

Introduced
3/27/25  
America’s Red Rock Wilderness Act

Primary Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1185

Introduced
3/27/25  
FIGHTING for America Act of 2025 Fighting Illicit Goods, Helping Trustworthy Importers, and Netting Gains for America Act of 2025